Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
chronic inflammation
Biotech
Rasayana Tx ingests GI candidate in $36M deal
Rasayana is paying Theriva Biologics $300,000 upfront for an oral intestinal alkaline phosphatase meant to restore balance to inflamed guts.
Darren Incorvaia
Feb 18, 2026 10:40am
MyMD's drug shows promise against age-related inflammation
Jul 31, 2023 11:07am
Washing out WASH protein complex drives inflammation in mice
Sep 26, 2022 10:10am
Vasella helps Numab to CHF22M round ahead of cancer trial start
Mar 9, 2020 7:00am
Nodthera nets $40M to take on chronic inflammation
Jun 25, 2018 2:00am
SetPoint Medical nabs $30M for bioelectronics rheumatoid arthritis trial
Aug 28, 2017 9:36am
